كل ما تريد معرفته عن امتحان الأيليتس
يعني إيه أيليتس ؟؟
IELTS = International English Language Testing System
ايه الهيئات المسؤولة عن الايليتس ؟؟
IELTS is jointly managed by the University of Cambridge ESOL
Examinations (Cambridge ESOL), British Council and IDP: IELTS
Australia.
أنواع الايلتس :
Academic and General Training
IELTS is available in two formats – Academic and General
Training.
The Academic Reading and Writing tests assess whether
a candidate is ready to study or train in the medium of English
at an undergraduate or postgraduate level. Admission to
undergraduate and postgraduate courses is based on
the results of these tests.
The General Training Reading and Writing tests are not designed
to test the full range of formal language skills required for
academic purposes, but emphasise basic survival skills in a
broad social and educational context. General Training is
suitable for candidates who are going to English-speaking
countries to complete their secondary education, to undertake
work experience or training programmes not at degree level, or
for immigration purposes to Australia, Canada and New Zealand.
It is the responsibility of the candidate to inform the test
centre whether they wish to take the Academic or General
Training Modules. Centres are not responsible for providing
this information. The General Training Module is not offered
at all test administrations.
ايه أهمية الايلتس ؟؟
How would it help me?
IELTS covers all four language skills: Listening, Reading, Writing and Speaking,
IELTS is offered in two test formats: Academic is suitable for candidates planning to undertake higher education study; General Training is suitable for candidates planning to undertake non-academic training, or for immigration or work purposes.
Candidates are given a score from 1 to 9 which shows their ability in each of the four tests, and an overall score of 1 to 9.
Listening 4 sections, 40 items, 40 minutes
Academic Reading 3 sections, 40 items,60 minutes
General Training Reading,3 sections, 40 items,60 minutes
Academic Writing 2 tasks (150 & 250 words),60 minutes
General Training Writing 2 tasks (150 & 250 words),60 minutes
Speaking 10-15 minutes
IELTS is recognised by universities and employers in many
countries, including Australia, Canada, New Zealand, the UK
and the USA. It is also recognised by professional bodies,
immigration authorities and other government agencies.
كتير من مجالات العمل دلوقت سواء في الوطن العربي أو برا … بيطلبوا وجود شهادة الايليتس مع المتقدم للشغل … وأهميتها بتظهر أكتر للناس اللي عايزة تهاجر للعمل أو حتى للدراسة …
ملف باور بوينت بعنوان
Natural hypertension
روابط التحميل
http://www.mediafire.com/file/nzyyjmgv42x/Natural Anti0hypertensive.rar
أو
http://rapidshare.com/files/285910232/Natural_Anti0hypertensive.rar.html
مشاركة من د- الأسرة الكريمة
المصدر : منتدى عالم الصيادلة
ملف باور بوينت بعنوان
diuretic drug (furosemide) ex . Lasix
روابط التحميل
http://www.mediafire.com/file/vmgnwnwyjuq/Furosemide (lasix).rar
أو
http://rapidshare.com/files/285910232/Natural_Anti0hypertensive.rar.html
مشاركة من د- الأسرة الكريمة
المصدر : منتدى عالم الصيادلة
Prepare your self for ICDL (exams & answers)
أسئلة امتحانات مع اجاباتها على ملفات باور بوينت
أولا :
IT امتحان ال
http://www.4shared.com/file/137616875/77dc2bbf/IT_with_answer.html
ثانيا :
Windows امتحان ال
http://www.4shared.com/file/137618619/c2719a2b/win.html
ثالثا
Word امتحان ال
http://www.4shared.com/file/137620160/73b7f0f2/Word_Presentation.html
رابعا
Excel امتحان ال
http://www.4shared.com/file/137620892/15f0b69e/Excel_Presentation.html
خامسا :
Powerpoint امتحان ال
http://www.4shared.com/file/137621532/5f7baa22/power_point_Presentation.html
سادسا :
Access امتحان ال
http://www.4shared.com/file/137622209/f47e9902/Access_Presentation.html
Four Vaccines Approved for Treating the 2009 H1N1 Influenza
On September 15, the FDA announced that it has approved 4 vaccines against the 2009 influenza A (H1N1) virus, formerly known as “swine flu.” The vaccine lots are expected to be available and distributed within the next 4 weeks.
FDA Commissioner of Food and Drugs Margaret A. Hamburg, MD, said she thought the approval was good news for the nation’s response to the H1N1 influenza virus. “This vaccine will help protect individuals from serious illness and death from influenza,” she said.
The approval comes at a time when the Centers for Disease Control and Prevention (CDC) is reporting that visits to physicians around the country for influenza-like illness are increasing and are higher than expected at this time of year. The vaccines that are currently available against 3 seasonal influenza virus strains will not protect against the 2009 H1N1 virus.
The FDA said that the vaccines, based on early data, effectively elicit an immune response in most healthy adults about 8 to 10 days after vaccination. Clinical studies are still underway to produce an optimal dose for children, with results expected in the near future.
Meanwhile, the CDC stresses that influenza is primarily spread through person-to-person contact, by the coughing or sneezing of infected people, and recommends that infected people stay home and limit their contact with others to keep from infecting them.
The newly approved vaccines are being made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and Sanofi Pasteur Inc. All 4 firms reportedly use the same processes to manufacture the H1N1 vaccines. As with the seasonal influenza vaccine, some lots of the H1N1 vaccine will contain the preservative thimerosal and others will not. The FDA has been continuing its efforts toward reducing thimerosal use in vaccines.
The FDA warns that persons with known allergies to chicken eggs or any other substance in the vaccine should probably not be vaccinated, although in the ongoing clinical trials, the vaccines have been well tolerated. The most common adverse effect is soreness at the injection site; other adverse effects can include a mild fever, body aches, and fatigue for a couple of days after vaccination. For the nasal spray delivery system, the most common adverse effects were runny nose, nasal congestion in all ages, sore throats in adults, and fever in children aged 2 to 6 years.
The FDA is working with different organizations regarding adverse event monitoring, information sharing, and an overall analysis during and after the 2009 H1N1 vaccination program, according to the news release. “As with any medical product, unexpected or rare serious adverse events may occur,” the FDA notes
Source : MedScape
لو مطلوب منك بحث … أو عرض تقديمي عن انفلونزا الخنازير
H1N1 موقع متخصص عن فيروس
Clinical Research is a new trend for pharmacists .. Minds introduces a new workshop which is the FIRST in Egypt
Content:
1. Introduction to clinical trials.
2. Clinical research approach.
3. Drug development process.
4. Initiating the study.
5. Monitoring & study close.
6. Test + case report form workshop.
Place:
محرم بيه – الرصافة – بجوار معهد الخدمة الإجتماعية – أمام سوبر ماركت التمساح – قاعة زويل الدور السادس
Date:
July 9th & 10th, from 3 p.m. to 7 p.m.
* Certified from Minds for training & development.
Price:
250
((وأسعار خاصة للمجموعات ))
Registration:
جمعية صحابة الخير فرع لوران – ش فهمي ويصا المتقاطع عمودياً على شارع ش شعراوي خلف الوطنية مول- 035851147
Contact us: 0111945352 – 0121677067
e-Mail: info@minds-online.com
Web site: www.minds-online.co
Visit us & invite others:
http://www.facebook.com/group.php?gid=92258047886
